≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_NONHODGKIN_EXALLC for full statistics.

Non-Hodgkin lymphoma, all

Endpoint Browser

C3_NONHODGKIN

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C82, C83, C84, C85
  • Cause of death: ICD-9 — 200
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 967[0-9]|970[0-2]
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

1436

4. Check minimum number of events

None

1436

5. Include endpoints

None

1436

6. Filter based on genotype QC (FinnGen only)

1436

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF9

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1436 470 966
Unadjusted period prevalence (%) 0.34 0.16 0.43
Median age at first event (years) 71.67 70.73 72.12

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1247
Matched controls
12472
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
2465.2
323.0
345
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
103.3
323.0
382
53
C83.1
ICD-10 Finland
Mantle cell lymphoma
2052.6
323.0
307
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
83.5
323.0
802
263
L03AA02
ATC
filgrastim; parenteral
39.0
269.3
345
121
XW000
NOMESCO Finland
Bone marrow biopsy
21.9
263.9
405
268
L03AA13
ATC
pegfilgrastim; parenteral
26.4
208.1
296
145
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.7
203.1
320
214
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
89.1
195.1
215
29
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
39.5
193.2
246
77
JN4BD
NOMESCO Finland
Extensive body CT
8.7
188.3
472
819
WW500
NOMESCO Finland
Blood transfusion
16.2
184.9
315
254
M04AA01
ATC
allopurinol; systemic
6.4
173.4
578
1477
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.8
166.4
332
373
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
40.2
162.6
206
61
A03FA01
ATC
metoclopramide; systemic, rectal
5.7
149.4
540
1464
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
42.6
136.0
170
46
C84.0
ICD-10 Finland
Mycosis fungoides
463.1
128.3
126
*
1XC02
NOMESCO Finland
NA
74.8
118.4
134
20
D70.82
ICD-10 Finland
Drug-induced neutropenia
30.0
114.9
156
59
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
17.6
112.0
181
119
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
12.8
110.0
205
189
PJA10
NOMESCO Finland
Exploration of lymph nodes
33.5
108.4
143
48
A04AA01
ATC
ondansetron; systemic, rectal
9.1
107.6
243
323
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.0
101.1
384
1018
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
43.0
97.2
121
31
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
112.1
95.5
103
10
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
24.9
93.8
134
60
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
28.7
92.6
127
49
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
89.7
85
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
73.0
88.9
101
15
ZX120
NOMESCO Finland
Intravenous
5.4
87.4
299
692
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
85.7
85.4
95
12
H02AB06
ATC
prednisolone; systemic
3.2
83.2
786
4310
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
34.0
83.2
109
35
R50.9
ICD-10 Finland
Fever, unspecified
4.3
80.4
348
1020
L01AA02
ATC
chlorambucil; oral
56.2
75.3
89
17
C83.00
ICD-10 Finland
Lymphocytic lymphoma
78.4
72.1
81
11
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
738.8
71.8
70
*
A04AA02
ATC
granisetron; systemic, transdermal
7.0
70.6
187
307
H02AB02
ATC
dexamethasone; systemic
4.9
69.5
252
608
L03AA14
ATC
lipegfilgrastim; parenteral
19.2
65.3
101
57
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
84.9
64.7
72
9
Z51.5
ICD-10 Finland
Palliative care
5.1
64.7
226
521
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
94.0
64.6
71
8
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
42.7
64.4
80
20
JN4AD
NOMESCO Finland
Body CT examination
5.0
63.9
226
527
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
14.8
63.7
109
80
JN6AD
NOMESCO Finland
CT of torso and neck
24.8
61.9
88
38
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.1
57.2
103
85
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.6
53
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
18.9
54.9
85
48
WW409
NOMESCO Finland
Other aferesis
+∞
54.6
52
*
N02AA05
ATC
oxycodone; systemic
3.2
54.4
355
1395
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.3
53.9
125
166
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
52.8
178
389
H02AB07
ATC
prednisone; oral
3.2
50.6
310
1155
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.2
50.3
144
258
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
49.3
47
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.1
48.3
123
188
WF004
NOMESCO Finland
Palliative radiotherapy
9.5
47.8
101
114
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
474.6
46.6
46
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
40.5
46.3
58
15
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
101.9
45.1
49
5
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
45.1
43
*
J05AB11
ATC
valaciclovir; oral
3.5
44.7
235
773
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
21.4
43.9
65
32
C82.1
ICD-10 Finland
Follicular lymphoma grade II
33.1
43.6
57
18
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
12.1
43.2
80
70
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
95.4
42.1
46
5
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
22.0
41.7
61
29
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
30.2
41.2
55
19
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
20.3
39.9
60
31
TGC00
NOMESCO Finland
Bronchial lavation
7.8
39.8
95
131
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
39.2
255
971
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
65.0
38.3
44
7
ZX112
NOMESCO Finland
Subcutaneous
7.7
37.8
90
124
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.8
37.7
133
302
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
37.7
36
*
B72
ICPC
Hodgkin Lymphoma
134.0
36.9
39
*
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
190.4
35.9
37
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
356.7
35.1
35
*
WW402
NOMESCO Finland
Leucoferesis
58.9
34.4
40
7
390
Kela drug reimbursment
Ibrutinib
95.3
33.9
37
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
33.6
124
294
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
33.5
32
*
J01MA12
ATC
levofloxacin; systemic
2.4
33.0
344
1710
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.5
32.0
86
141
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
9.0
31.2
67
78
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
31.0
204
772
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
320.4
31.0
31
*
ZX108
NOMESCO Finland
Inhalation
16.9
30.8
49
30
XX9CD
NOMESCO Finland
Very extensive complementary CT
59.9
30.2
35
6
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
16.6
30.0
48
30
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
158.7
29.8
31
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
158.7
29.8
31
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
29.3
28
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
32.6
29.2
38
12
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.6
29.1
60
65
YNB10
NOMESCO Finland
Collection of stem cells for transplant
37.0
28.5
36
10
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
28.2
27
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
9.7
27.9
57
61
A02BC02
ATC
pantoprazole; systemic
2.0
27.7
819
6153
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
27.1
401
2304
212
Kela drug reimbursment
Gout
5.2
27.1
87
178
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
42.2
26.9
33
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
26.4
291
1462
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
14.1
26.4
45
33
9671/3-C42.1
ICD-O-3
Lymphoplasmacytic lymphoma of bone marrow
+∞
26.1
25
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
26.1
122
359
D69.5
ICD-10 Finland
Secondary thrombocytopenia
41.0
25.9
32
8
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.2
25.6
51
52
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
25.5
621
4288
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.4
25.1
94
226
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.0
25.0
106
286
1512
Kela drug reimbursment
Ibrutinib
71.4
24.9
28
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
24.6
222
1006
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
28.2
24.5
33
12
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.2
24.5
78
158
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
23.5
449
2819
TAB00
NOMESCO Finland
Lumbar puncture
5.0
23.1
76
160
L01XE27
ATC
[U] ibrutinib; oral
66.2
22.9
26
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
53.0
22.1
26
5
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
223.6
21.7
22
*
WZC30
NOMESCO Finland
Teaching
2.4
21.5
195
879
1AA09
NOMESCO Finland
NA
44.1
21.5
26
6
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
78.1
20.7
23
*
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
213.3
20.6
21
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
22.8
20.4
29
13
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
27.5
20.1
27
10
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
58.5
19.9
23
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
58.5
19.9
23
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.2
19.9
111
371
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
19.8
19
*
C84.1
ICD-10 Finland
Sézary disease
+∞
19.8
19
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
203.0
19.6
20
*
WW200
NOMESCO Finland
Immunization
5.5
19.4
58
110
L26
ICD-10 Finland
Exfoliative dermatitis
34.9
18.9
24
7
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
34.9
18.9
24
7
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
18.8
18
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
+∞
18.8
18
*
L01EL01
ATC
ibrutinib; oral
101.5
18.6
20
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
192.7
18.6
19
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
18.4
107
371
C82.0
ICD-10 Finland
Follicular lymphoma grade I
+∞
17.7
17
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
17.7
17
*
J05AB01
ATC
aciclovir; systemic
2.0
17.7
251
1381
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.5
17.7
153
671
A07AA02
ATC
nystatin; oral
2.9
17.6
114
423
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
182.4
17.5
18
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
17.2
67
168
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.0
17.2
69
178
EMA10
NOMESCO Finland
Biopsy of tonsil
22.2
16.9
24
11
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.7
16
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.9
16.7
29
23
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
7.4
16.6
39
54
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
172.1
16.5
17
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
16.1
164
780
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
17.0
16.1
25
15
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
16.0
117
467
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.7
15
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
15.7
15
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.3
15.6
58
140
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
15.6
175
869
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.6
15.3
53
119
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
16.3
15.3
24
15
A98
ICPC
Health maint/preventive medicine
0.6
15.2
778
9153
127
Kela drug reimbursment
Transplant complication
6.9
15.0
37
55
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
15.0
271
1621
J01MA14
ATC
moxifloxacin; systemic
2.3
15.0
142
653
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
14.6
14
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
36.5
14.5
18
5
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.1
14.4
56
141
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
12.7
14.4
25
20
D07AB08
ATC
desonide; topical
2.3
14.3
142
664
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
7.8
14.2
32
42
E83.50
ICD-10 Finland
Hypercalcemia
7.3
14.1
33
46
L01BB05
ATC
fludarabine; systemic
30.4
13.9
18
6
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
7.9
13.9
31
40
134
Kela drug reimbursment
General erythroderma
17.8
13.8
21
12
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
13.8
207
1156
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
75.9
13.6
15
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
13.6
13
*
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
13.6
13
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
13.5
149
734
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
141.4
13.5
14
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
13.0
13.4
23
18
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
18.4
13.4
20
11
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
14.0
13.3
22
16
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.5
13.1
61
180
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.8
13.1
55
149
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
13.0
138
667
J02AC03
ATC
voriconazole; systemic
28.7
13.0
17
6
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.8
12.9
29
38
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.6
12.7
29
39
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
70.6
12.6
14
*
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
32.4
12.6
16
5
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
32.4
12.6
16
5
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
12.5
12
*
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
+∞
12.5
12
*
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
12.5
12
*
D05BB02
ATC
acitretin; oral
4.6
12.5
43
97
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
20.3
12.5
18
9
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
12.5
282
1803
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
131.2
12.5
13
*
B01AB10
ATC
tinzaparin; parenteral
2.4
12.0
102
443
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
21.5
12.0
17
8
JN4CD
NOMESCO Finland
Very extensive body CT
2.8
11.9
75
275
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
11.8
11.8
21
18
H02AB09
ATC
hydrocortisone; systemic
4.4
11.7
42
99
1XX25
NOMESCO Finland
NA
+∞
11.5
11
*
9670/3-C42.1
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of bone marrow
+∞
11.5
11
*
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
11.5
11
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
7.6
11.5
26
35
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
121.0
11.4
12
*
B02.9
ICD-10 Finland
Zoster without complication
2.5
11.4
86
352
L01CB01
ATC
etoposide; systemic
12.8
11.1
19
15
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
11.1
68
243
A41.8
ICD-10 Finland
Other specified sepsis
4.5
11.0
38
87
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
5.4
10.9
32
61
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
12.0
10.8
19
16
L04AD01
ATC
ciclosporin; systemic
5.5
10.8
31
58
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
18.0
10.7
16
9
TK800
NOMESCO Finland
Hemodialysis
3.9
10.6
43
114
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
60.5
10.6
12
*
L41.8
ICD-10 Finland
Other parapsoriasis
110.9
10.4
11
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
10.4
10
*
ZX196
NOMESCO Finland
NA
+∞
10.4
10
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.4
10.3
26
41
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
8.3
10.3
22
27
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
10.3
500
3843
B01AB05
ATC
enoxaparin; parenteral
1.6
10.2
362
2593
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
26.2
9.8
13
5
N05CF01
ATC
zopiclone; oral
1.5
9.6
417
3115
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.9
9.6
30
62
ZX131
NOMESCO Finland
Intrathecal
100.7
9.4
10
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
30.2
9.4
12
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
9.4
9
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
9.4
9
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
9.4
9
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.8
9.4
30
64
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
21.9
9.4
13
6
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
6.3
9.1
23
37
ED1AA
NOMESCO Finland
Mandipular X-ray examination
9.1
9.0
18
20
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
18.7
8.9
13
7
6BA02
NOMESCO Finland
NA
18.7
8.9
13
7
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
4.2
8.8
32
78
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
6.0
8.8
23
39
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
8.7
133
744
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
14.1
8.7
14
10
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
8.7
303
2146
3AA13
NOMESCO Finland
NA
50.3
8.7
10
*
1CX01
NOMESCO Finland
NA
16.4
8.6
13
8
JAL00
NOMESCO Finland
Biopsy of peritoneum
16.4
8.6
13
8
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
8.5
54
200
AAA10
NOMESCO Finland
Biopsy through craniotomy
27.7
8.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.2
8.5
42
133
C03CA01
ATC
furosemide; systemic
1.4
8.4
485
3822
C83.7
ICD-10 Finland
Burkitt lymphoma
+∞
8.3
8
*
C83.71
ICD-10 Finland
Burkitt's tumour
+∞
8.3
8
*
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
8.3
8
*
3AX16
NOMESCO Finland
NA
+∞
8.3
8
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
14.6
8.2
13
9
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
33.6
8.1
10
*
9680/3-C16.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of stomach, NOS
33.6
8.1
10
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
11.8
8.1
14
12
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
9.0
8.0
16
18
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
22.2
8.0
11
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
8.0
348
2583
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.7
8.0
51
191
A10BK03
ATC
empagliflozin; oral
0.3
8.0
12
457
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.4
7.9
36
107
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.9
276
1953
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.5
7.9
61
254
J02AC01
ATC
fluconazole; systemic
1.5
7.8
305
2207
JFB00
NOMESCO Finland
Partial resection of small intestine
3.7
7.8
32
88
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
45.2
7.7
9
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.0
7.7
29
74
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.3
7.6
66
293
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
18.5
7.6
11
6
B74
ICPC
Malignant neoplasm blood other
11.9
7.6
13
11
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
25.2
7.6
10
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.4
7.6
63
275
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
80.5
7.4
8
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
80.5
7.4
8
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
80.5
7.4
8
*
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
80.5
7.4
8
*
J35.1
ICD-10 Finland
Hypertrophy of tonsils
7.7
7.4
16
21
GEA00
NOMESCO Finland
Mediastinoscopy
13.4
7.4
12
9
R06AE07
ATC
cetirizine; oral
1.4
7.4
390
3000
L01AA01
ATC
cyclophosphamide; systemic
6.9
7.3
17
25
3AF07
NOMESCO Finland
NA
+∞
7.3
7
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
7.3
7
*
9680/3-C09.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of tonsil, NOS
+∞
7.3
7
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
7.3
7
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.3
7.3
34
104
A79
ICPC
Malignancy NOS
3.8
7.3
29
78
A02BC01
ATC
omeprazole; systemic
1.5
7.2
338
2539
A05AA02
ATC
ursodeoxycholic acid; oral
4.8
7.2
22
46
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
30.2
7.1
9
*
L04AA06
ATC
mycophenolic acid; systemic
4.2
7.1
25
60
E0000UV
ATC
NA
1.4
7.1
391
3030
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
5.9
6.9
18
31
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
13.8
6.9
11
8
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.8
494
4007
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.1
6.8
70
336
120
Kela drug reimbursment
Hypogammaglobulinaemia
16.8
6.7
10
6
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
4.3
6.7
23
54
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
6.7
83
431
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
22.6
6.7
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
6.7
98
543
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
6.5
6.6
16
25
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
6.6
150
2194
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
4.4
6.5
22
51
9591/3-C16.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS
70.2
6.4
7
*
L41.4
ICD-10 Finland
Large plaque parapsoriasis
70.2
6.4
7
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
70.2
6.4
7
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
70.2
6.4
7
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
14.4
6.4
10
7
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
14.4
6.4
10
7
N03AX16
ATC
pregabalin; oral
1.5
6.4
249
1795
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
6.6
6.3
15
23
JMA10
NOMESCO Finland
Transabdominal total splenectomy
6.6
6.3
15
23
D07AA02
ATC
hydrocortisone; topical
1.7
6.3
130
802
C10AA07
ATC
rosuvastatin; oral
0.6
6.3
130
1943
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
18.1
6.3
9
5
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
+∞
6.3
6
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
6.3
6
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
6.3
6
*
2AX05
NOMESCO Finland
NA
+∞
6.3
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
9670/3-C77.4
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg
+∞
6.3
6
*
D07AC01
ATC
betamethasone; topical
1.4
6.2
357
2771
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
5.8
6.1
16
28
L01
ICPC
Neck symptom/complaint
0.5
6.1
37
771
C10AA01
ATC
simvastatin; oral
0.7
6.1
423
5119
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.8
6.1
36
131

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017143) Hepatitis C virus Ab [Presence] in Serum
502
813
8.96
319.65
1.6
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
511
864
8.63
312.73
1.6
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
552
1026
8.12
309.68
1.7
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
314
219
18.07
307.65
1.9
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
224
73
36.17
307.65
3.0
1.9
e9/l
1.2
1.0
0.56
150
39
(3045142) Bone marrow Pathology biopsy report
297
121
30.69
307.65
1.8
1.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
792
1488
10.64
307.65
9.6
3.8
u/l
316.7
244.4
6.59
771
1397
(40768795) Lymph node Pathology biopsy report
253
89
34.29
307.65
1.4
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
471
512
13.20
307.65
1.5
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
274
207
16.12
299.12
5.6
5.3
iu/ml
5812.9
936.5
0.44
42
29
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
183
51
40.98
297.93
2.3
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
192
67
32.93
292.60
1.4
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
182
54
38.45
291.16
2.3
1.9
%
75.3
70.5
0.92
171
48
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
179
52
39.18
288.00
2.3
1.8
%
13.4
13.8
0.06
90
23
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
230
154
17.59
267.19
2.8
2.8
u/ml
32464.4
531.4
0.84
27
17
(4035726)
472
937
7.01
243.07
1.9
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
157
54
32.52
239.61
3.2
1.9
e6/l
577.0
643.1
0.15
129
45
(21494815) CD4 cells/100 lymphocytes in Specimen
155
57
30.36
231.33
2.1
1.7
%
21.5
37.0
—
14
8
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
149
52
31.86
226.15
3.3
1.9
e9/l
0.2
0.2
0.11
128
45
(3005719) IgG [Mass/volume] in Serum or Plasma
401
747
7.06
218.04
4.4
2.6
g/l
8.4
10.9
12.75
378
672
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
137
57
26.46
195.31
3.5
2.0
e6/l
345.1
757.8
2.44
53
25
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
185
173
12.13
174.95
1.5
1.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
98
28
37.49
157.16
2.4
2.1
%
9.4
12.3
0.27
87
23
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
162
151
11.97
153.12
1.4
1.4
u/ml
129.5
108.0
0.43
36
28
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
82
13
66.84
149.24
1.9
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
299
594
6.09
148.80
3.8
1.8
g/l
2.5
1.6
1.78
276
534
(3017181) Myelocytes/100 leukocytes in Blood
364
896
5.10
141.95
6.4
4.1
%
0.9
0.9
0.01
238
299
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
198
267
8.44
141.79
2.6
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
128
93
15.01
140.61
1.6
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
202
282
8.17
140.42
2.6
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
168
207
9.06
129.22
2.6
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
82
25
34.73
128.84
2.2
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
78
21
39.22
126.80
2.3
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
165
210
8.75
123.53
5.2
4.0
%
1.4
1.7
0.26
136
164
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
101
61
17.73
122.03
4.3
2.8
%
30.4
39.9
1.69
47
21
(40765096) Chromosome analysis panel by Banding
89
43
22.00
118.94
1.2
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
678
3019
3.36
109.60
7.6
2.8
umol/l
1324.6
8518.3
7.24
652
2527
(3002179) Metamyelocytes/100 leukocytes in Blood
303
796
4.56
106.91
6.2
4.0
%
0.5
0.6
0.50
151
217
(42870588) Differential panel, method unspecified - Blood
750
3645
3.21
102.87
12.1
5.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
307
846
4.34
101.42
6.8
4.2
%
0.1
0.1
0.20
206
275
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
142
194
8.01
99.79
1.8
1.5
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
876
4764
3.15
96.78
12.4
5.6
%
0.6
0.6
1.21
851
4418
(3027945) Reticulocytes/100 erythrocytes in Blood
446
1642
3.49
96.21
4.2
2.4
%
1.9
1.8
0.59
411
1436
(3012095) Magnesium [Moles/volume] in Serum or Plasma
486
1919
3.32
93.19
8.0
3.1
mmol/l
0.8
0.8
2.30
469
1782
(3019069) Monocytes/100 leukocytes in Blood
884
4899
3.09
93.16
13.2
6.0
%
9.6
9.0
4.43
861
4555
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
126
164
8.33
92.12
2.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
140
208
7.35
91.23
1.4
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
878
4888
3.05
90.99
12.7
5.7
%
2.4
2.8
4.23
854
4523
(3002030) Lymphocytes/100 leukocytes in Blood
886
4989
3.03
89.34
13.1
5.9
%
26.1
25.5
0.63
861
4602
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
122
159
8.29
89.05
1.8
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
106
117
9.70
88.21
2.9
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
84
66
13.46
87.72
1.3
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
429
1650
3.28
84.87
7.3
5.6
mmol/l
1.1
1.0
1.77
409
1514
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
120
163
7.94
84.52
1.4
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
116
152
8.21
84.23
1.9
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
861
4895
2.90
83.06
11.7
5.7
%
57.2
58.9
2.86
839
4546
(3004588) Protein electrophoresis panel - Serum or Plasma
301
939
3.79
82.46
3.4
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
100
112
9.52
82.24
3.0
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
887
5152
2.89
81.62
11.3
5.4
e9/l
0.6
0.6
0.56
829
4381
(3006315) Basophils [#/volume] in Blood
887
5170
2.87
80.75
11.4
5.4
e9/l
0.0
0.0
6.23
830
4412
(3037692) Legionella sp identified in Specimen by Organism specific culture
65
39
17.41
78.43
1.3
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
343
1204
3.43
78.10
4.5
2.5
e9/l
71.4
68.3
0.77
287
935
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
117
171
7.36
77.17
1.9
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
897
5340
2.81
76.95
12.5
5.6
e9/l
0.2
0.2
4.26
840
4632
(3019198) Lymphocytes [#/volume] in Blood
889
5275
2.80
76.64
11.6
5.5
e9/l
1.8
1.8
0.19
836
4577
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
169
358
5.22
76.37
1.8
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
104
136
8.17
75.54
1.9
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
55
25
22.84
74.99
4.6
1.8
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
90
100
9.53
74.38
1.7
2.1
mg/l
4.3
4.5
0.09
85
95
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
106
152
7.45
71.04
1.3
1.2
u/ml
329.9
260.0
0.74
59
83
(3008757) Leukocyte morphology finding [Identifier] in Blood
102
143
7.60
69.73
6.3
4.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
74
69
11.25
69.21
4.7
4.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
53
27
20.34
68.87
1.3
1.3
—
—
—
0
0
(44790049)
94
125
7.98
67.23
1.7
1.5
—
—
—
0
0
(44806118)
94
125
7.98
67.23
1.7
1.5
—
—
—
0
0
(44790048)
94
125
7.98
67.23
1.7
1.5
—
—
—
0
0
(44790047)
94
125
7.98
67.23
1.7
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
56
36
16.15
65.16
1.5
2.7
u/ml
8564.9
55755.1
—
8
8
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
76
82
9.73
64.11
2.9
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
307
1125
3.20
64.06
4.0
2.8
g/l
63.9
66.0
3.24
294
1020
(3025159) Blasts/100 leukocytes in Blood
247
794
3.55
63.65
6.4
4.3
%
0.1
0.5
0.55
155
236
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
271
930
3.36
62.94
2.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
140
306
4.96
60.68
1.5
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
181
487
4.11
60.23
2.5
2.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
667
3750
2.45
59.28
9.9
4.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
70
78
9.38
57.60
1.5
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
922
6041
2.47
57.47
31.6
8.5
e9/l
3.8
4.4
11.94
881
5226
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
78
106
7.72
54.66
3.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
78
106
7.72
54.66
3.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
78
106
7.72
54.66
3.4
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
38
15
25.99
54.42
1.4
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
52
47
11.44
49.51
4.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
52
47
11.44
49.51
4.0
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
129
313
4.43
48.97
1.5
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
52
48
11.20
48.83
4.0
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
81
133
6.39
47.65
5.5
3.5
%
57.6
56.2
0.14
50
93
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
155
446
3.77
46.58
3.4
3.5
ratio
21.2
1.6
—
10
42
(3034860) Kappa light chains.free [Mass/volume] in Serum
157
459
3.72
46.09
3.4
3.5
mg/l
70.9
70.4
0.01
129
381
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
157
460
3.71
45.94
3.4
3.5
mg/l
37.8
73.4
0.74
127
385
(3019832) Treponema pallidum Ab [Presence] in Serum
129
331
4.18
45.46
1.4
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
32
13
25.15
45.24
1.5
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
409
2038
2.41
45.23
10.7
4.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
61
78
8.12
44.94
2.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
95
193
5.20
44.62
2.1
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
55
63
9.04
44.23
2.1
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
55
63
9.04
44.23
2.1
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
72
114
6.60
43.85
1.5
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
787
5171
2.15
43.70
11.1
4.8
g/l
31.9
34.4
24.91
753
4767
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
47
44
11.01
43.68
1.2
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
178
585
3.33
43.56
2.7
1.8
ug/l
2.4
2.2
0.06
166
500
(40758292) HTLV I+II Ab panel - Serum
34
18
19.32
43.21
2.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
126
337
4.00
41.91
3.5
3.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
859
5895
2.14
41.86
18.3
6.2
umol/l
10.9
12.5
4.38
840
5551
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
188
661
3.12
41.04
1.9
1.8
g/l
1.7
1.5
1.23
142
576
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
53
64
8.56
40.88
4.1
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
53
64
8.56
40.88
4.1
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
53
64
8.56
40.88
4.1
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
53
64
8.56
40.88
4.1
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
163
534
3.32
39.99
3.8
2.5
g/l
3.9
3.8
0.04
119
389
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
163
535
3.31
39.86
3.8
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
163
536
3.30
39.74
3.8
2.5
g/l
7.1
7.5
1.52
120
402
(3028433) Virus identified in Specimen by Culture
40
34
12.07
39.54
1.4
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
339
1645
2.39
39.10
2.3
1.5
g/l
2.1
2.9
3.76
282
930
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
93
209
4.69
38.75
6.2
3.5
%
54.3
60.2
2.74
93
209
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
68
116
6.10
38.46
1.4
1.3
miu/ml
158.4
222.5
0.34
11
45
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
419
2243
2.23
38.20
3.1
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
62
98
6.57
37.79
2.3
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
74
140
5.52
37.57
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
142
455
3.35
36.00
3.8
2.7
g/l
1.8
1.4
0.37
125
390
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
149
494
3.25
35.74
4.1
2.6
g/l
3.3
3.1
1.21
120
396
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
721
9588
0.50
35.33
5.3
6.6
mmol/mol
41.0
41.2
0.11
631
8690
(3001964) Herpes simplex virus Ag [Presence] in Specimen
36
32
11.51
34.55
1.4
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
149
506
3.17
34.31
3.5
2.6
g/l
9.9
10.6
0.66
134
432
(3008536) Aspergillus sp Ab [Presence] in Serum
36
33
11.16
33.86
2.8
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
79
174
4.75
33.70
6.5
6.5
mg/l
12.0
12.3
0.16
72
161
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
315
1570
2.29
33.62
2.7
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
340
1757
2.23
33.20
2.1
2.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
126
400
3.36
32.36
3.4
2.6
g/l
0.1
0.0
0.44
118
364
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
29
21
14.07
31.42
1.9
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
67
137
5.08
31.18
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
263
1255
2.34
30.85
1.9
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
790
10048
0.52
30.47
4.3
5.3
mmol/l
2.6
2.5
0.50
684
9020
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
747
9659
0.53
30.32
3.9
4.7
mmol/l
1.3
1.4
9.00
651
8642
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
306
1574
2.20
29.90
2.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
444
2628
2.00
29.80
24.5
6.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
64
132
5.03
29.49
3.9
2.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
135
473
3.05
29.37
1.8
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
26
18
14.69
28.83
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
83
217
4.00
28.38
1.8
1.3
e6/l
137.9
729.8
0.62
73
177
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
83
217
4.00
28.38
1.8
1.3
e6/l
99.5
42.8
0.42
73
173
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
767
9769
0.54
28.28
4.3
4.7
mmol/l
4.4
4.4
0.07
678
8826
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
257
1263
2.26
27.92
5.3
2.8
umol/l
7.1
10.2
2.74
236
1112
(3032352) Blasts [#/volume] in Cerebral spinal fluid
34
8
43.44
27.80
1.6
2.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
541
3487
1.88
27.75
9.6
4.1
ph
7.4
7.4
1.31
130
670
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
807
5895
1.84
27.63
13.8
6.9
mmol/l
1.2
1.2
5.37
677
4926
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
114
376
3.21
27.46
3.5
2.6
g/l
0.0
0.0
0.00
108
346
(3044290) Cell count panel - Cerebral spinal fluid
76
191
4.15
27.41
1.8
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
115
382
3.19
27.37
3.5
2.6
g/l
0.0
0.0
0.00
108
347
(3044640) Blood type and Crossmatch panel - Blood
554
3623
1.86
26.96
5.6
2.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
589
3932
1.84
26.79
9.1
3.3
mmol/l
2.3
2.3
2.76
554
3355
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
22
13
17.17
26.38
1.2
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
111
385
3.04
24.52
1.7
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
118
426
2.93
24.28
3.5
2.5
g/l
35.2
36.9
1.92
110
365
(3018677) aPTT in Platelet poor plasma by Coagulation assay
337
1936
1.97
23.88
3.5
2.0
s
29.3
30.2
1.31
328
1876
(3020779) Urea [Moles/volume] in Serum or Plasma
232
1176
2.16
23.05
7.1
6.7
mmol/l
11.4
11.4
0.01
225
1109
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
732
5372
1.74
22.98
12.0
6.2
mmol/l
1.2
1.2
1.92
703
4826
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
41
71
5.91
22.82
1.8
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
38
61
6.37
22.80
1.1
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
434
2768
1.81
21.97
4.8
2.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
39
7.84
21.73
1.2
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
40
71
5.77
21.71
1.8
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
25
26
9.77
21.48
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
22
19
11.74
21.38
1.5
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
383
2375
1.84
21.13
8.1
3.1
mmol/l
2.5
2.5
4.50
360
2071
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
111
418
2.79
21.10
1.9
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
58
145
4.13
21.07
1.2
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
128
522
2.59
20.81
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
754
9356
0.59
20.64
4.4
4.2
mmol/l
1.4
1.3
2.78
662
8297
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
40
75
5.46
20.50
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
36
61
6.03
20.48
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
20
16
12.66
20.34
1.9
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
79
253
3.25
19.95
1.2
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
36
64
5.74
19.51
1.6
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
121
500
2.55
19.13
3.2
2.6
u/ml
0.4
0.3
0.77
82
286
(3033658) Prothrombin time (PT) actual/Normal
433
2856
1.74
19.04
6.2
4.1
%
84.3
82.5
0.86
423
2786
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
85
294
3.01
18.85
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
85
294
3.01
18.85
1.5
1.4
—
—
—
0
0
(3012544) pH of Venous blood
234
1285
1.98
18.48
4.5
3.6
—
7.4
—
0
8
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
82
282
3.02
18.37
1.5
1.6
iu/ml
0.1
20.7
0.50
23
59
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
28
41
6.95
18.29
1.8
1.1
%
61.9
71.2
—
10
5
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
44
100
4.51
18.08
1.5
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
22
25
8.92
17.69
1.5
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
227
1252
1.97
17.65
4.6
3.6
mmol/l
1.8
2.1
0.44
187
983
(3016018) Differential panel - Cerebral spinal fluid
41
90
4.66
17.58
1.6
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
675
5086
1.62
17.36
9.1
4.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
82
292
2.92
17.28
2.2
3.0
mg/l
1.6
1.8
1.21
75
260
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
29
47
6.28
17.23
2.4
5.6
—
49.4
—
0
10
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
76
261
3.02
17.07
1.5
2.0
mg/l
10.8
12.3
0.79
68
238
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
34
65
5.33
17.07
1.5
1.1
mmol/l
3.2
2.0
1.15
34
60
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
838
9952
0.62
16.61
4.9
5.0
mmol/l
6.0
6.1
3.02
741
8812
(3021447) Carbon dioxide [Partial pressure] in Venous blood
225
1263
1.93
16.55
4.6
3.6
kpa
5.7
5.8
0.76
216
1223
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
132
608
2.29
16.40
4.9
3.8
mmol/l
24.5
24.2
0.50
126
545
(3023419) Bacteria identified in Sputum by Culture
59
181
3.36
15.98
2.0
2.3
—
—
—
0
0
(3026782) Osmolality of Urine
381
2527
1.69
15.96
3.1
3.0
mosm/kgh2o
550.4
561.1
0.49
344
2159
(3036048) Francisella tularensis Ab [Titer] in Serum
19
21
9.16
15.57
1.1
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
98
405
2.52
15.48
1.6
1.9
u/l
41.6
37.7
0.88
90
350
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
32
64
5.09
15.29
2.6
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
32
64
5.09
15.29
2.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
37
84
4.49
15.24
2.5
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
140
2628
0.48
15.23
2.0
1.6
mmol/l
1.4
1.3
0.82
119
2159
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
29
7.33
14.42
2.0
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
36
84
4.37
14.34
2.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
547
4062
1.56
14.08
2.6
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
192
1086
1.89
13.68
7.6
8.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
47
139
3.46
13.50
3.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
47
139
3.46
13.50
3.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
47
139
3.46
13.50
3.3
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
167
906
1.95
13.48
2.1
2.1
nmol/l
370.3
370.0
0.01
155
819
(3005988) Vibrio sp identified in Specimen by Organism specific culture
47
140
3.44
13.36
3.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
47
140
3.44
13.36
3.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
596
4551
1.53
13.31
20.6
10.4
e9/l
0.0
0.0
0.52
524
3692
(3007853) Bacteria identified in Skin by Aerobe culture
223
1337
1.79
13.15
2.0
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
61
4.83
13.10
1.2
1.5
u/l
120.8
7080.5
—
10
13
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
65
238
2.81
13.05
2.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
46
138
3.41
12.94
3.4
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
27
7.12
12.72
1.1
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
32
76
4.28
12.48
1.4
1.2
g/l
5.4
7.3
1.54
25
55
(3028192) IgG subclass 2 [Mass/volume] in Serum
32
76
4.28
12.48
1.4
1.2
g/l
2.6
2.6
0.02
25
56
(3024139) IgG subclass 3 [Mass/volume] in Serum
32
76
4.28
12.48
1.4
1.2
g/l
0.3
0.4
0.69
25
55
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
29
64
4.60
12.39
4.0
1.8
—
—
—
0
0
(4062490)
32
78
4.17
12.08
1.4
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
51
171
3.06
11.99
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
72
292
2.54
11.86
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
72
293
2.53
11.77
1.4
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
153
843
1.91
11.76
5.2
4.0
ph
7.4
7.4
1.06
16
109
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
572
4416
1.49
11.68
3.8
3.5
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
26
55
4.80
11.68
7.0
3.4
u/l
303.7
220.5
1.10
26
55
(42529406) Shigella sp [Presence] in Stool by Culture
72
295
2.52
11.61
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
35
94
3.79
11.60
1.7
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
11
10.99
11.07
2.2
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
11
10.99
11.07
2.2
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
11
10.99
11.07
2.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
52
185
2.88
11.04
1.2
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
152
856
1.87
10.92
5.2
4.0
kpa
5.0
5.2
1.16
143
787
(1616796) Gas panel - Central venous blood
71
298
2.45
10.89
3.4
4.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
495
3758
1.48
10.77
3.9
3.5
e6/l
45.6
100.3
1.67
420
2969
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
145
808
1.88
10.76
5.2
3.9
mmol/l
2.2
2.0
0.28
123
601
(3020393) Adenovirus Ag [Presence] in Stool
14
5
28.25
10.73
1.3
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
995
11086
0.67
10.70
60.2
25.9
e9/l
204.6
236.8
30.07
966
10721
(3000963) Hemoglobin [Mass/volume] in Blood
996
11092
0.67
10.64
60.3
26.1
g/l
119.6
133.0
95.31
970
10841
(3010813) Leukocytes [#/volume] in Blood
996
11092
0.67
10.64
60.1
25.9
e9/l
7.1
7.0
0.25
964
10685
(3026361) Erythrocytes [#/volume] in Blood
996
11089
0.67
10.59
60.0
25.9
e12/l
4.0
4.4
80.97
961
10685
(3052592) Norovirus Ag [Presence] in Stool
16
23
7.02
10.58
1.5
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
996
11088
0.67
10.57
59.9
25.8
fl
92.3
91.8
2.50
971
10837
(3035941) MCH [Entitic mass]
996
11088
0.67
10.57
59.8
25.8
pg
30.6
30.5
0.96
971
10835
(3003434) Protein [Mass/volume] in Pleural fluid
61
243
2.58
10.45
1.7
1.5
g/l
29.9
30.5
0.13
56
221
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
785
9126
0.69
10.42
4.4
4.5
mu/l
2.0
2.0
0.15
700
8103
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
20
37
5.47
10.41
1.3
1.1
ng/l
1180.6
89.8
—
13
6
(3003694) ABO and Rh group [Type] in Blood
356
2541
1.53
10.35
1.7
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
40
128
3.19
10.20
1.3
1.6
g/l
0.9
0.9
0.01
27
99
(3000850) Epithelial cells [#/volume] in Urine
370
2677
1.51
10.06
3.1
2.7
e6/l
3.8
4.3
0.75
339
2380
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
13
9.30
9.88
2.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
31
86
3.66
9.84
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
47
4.74
9.78
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
63
265
2.44
9.65
1.3
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
17
29
5.92
9.60
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
21
44
4.83
9.55
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
207
1323
1.66
9.55
6.4
3.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
14
8.64
9.35
2.2
1.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
967
10758
0.69
9.32
47.8
21.0
umol/l
89.8
86.8
0.97
967
10753
(3032080) INR in Blood by Coagulation assay
644
5242
1.41
9.26
11.5
11.7
inr
1.3
1.4
2.01
172
1443
(36304419) Bacteria [Presence] in Urine
431
3264
1.46
9.21
3.8
3.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
447
3419
1.45
9.02
3.8
3.4
e6/l
0.5
0.5
0.32
373
2659
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
54
219
2.52
8.95
1.1
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
12
15
8.06
8.87
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
79
380
2.14
8.86
1.4
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
49
192
2.61
8.72
1.8
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
191
2852
0.62
8.64
2.9
3.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
110
3.14
8.55
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
111
612
1.88
8.52
6.1
4.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
49
196
2.55
8.37
1.7
1.4
e6/l
73192.4
95663.8
0.15
34
121
(3018095) Leukocytes [#/volume] in Urine
529
4216
1.40
8.35
4.3
4.0
e6/l
98.3
136.5
0.36
428
3162
(3023199) Leukocytes [#/volume] in Pleural fluid
52
215
2.47
8.30
1.8
1.4
e6/l
1882.5
1520.3
0.39
42
157
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
54
4.12
8.27
1.1
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
173
1096
1.66
8.22
1.9
2.2
g/l
0.2
0.2
4.06
155
1011
(3048879) Bone marrow aspiration report
20
46
4.40
8.16
2.0
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
179
1148
1.64
8.11
6.2
6.9
mmol/l
2.0
1.4
2.52
169
1098
(3020682) Albumin/Creatinine [Ratio] in Urine
278
3774
0.67
7.91
3.2
4.0
mg/mmol
14.2
9.5
0.67
161
2463
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
43
4.46
7.91
1.1
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
941
10427
0.72
7.84
34.0
17.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
889
7765
1.38
7.82
6.7
4.1
mm/h
21.2
14.5
15.53
852
7074
(3019060) Gas panel - Arterial blood
150
928
1.69
7.80
7.0
4.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
842
9482
0.73
7.64
38.7
16.9
ml/min/173m2
74.5
72.5
1.75
774
7903
(3012501) Base excess in Blood by calculation
64
301
2.18
7.63
5.1
5.1
mmol/l
2.9
2.6
0.47
52
210
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
947
8373
1.38
7.63
22.0
7.6
u/l
88.3
81.2
3.76
922
7784
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
38
4.52
7.18
1.8
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
17
38
4.52
7.18
23.9
27.3
ug/l
122.1
123.5
0.02
11
33
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
61
289
2.16
7.16
1.3
1.2
—
6.8
—
0
5
(3045788) Cell count panel - Pleural fluid
42
169
2.53
7.13
1.7
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
25
75
3.37
7.12
3.7
3.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
986
10795
0.72
7.11
45.0
21.5
mmol/l
4.0
4.0
1.04
955
10470
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
27
5.23
6.97
1.0
1.0
miu/ml
1037.5
1402.3
0.50
14
27
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
48
4.00
6.90
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
48
4.00
6.90
1.1
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
986
10777
0.73
6.84
44.3
21.4
mmol/l
138.8
139.6
11.28
958
10461
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
91
506
1.85
6.84
6.8
4.2
mmol/l
25.6
24.9
1.34
86
466
(40768806) Pleura Pathology biopsy report
45
191
2.40
6.84
1.6
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
785
6807
1.34
6.76
8.1
5.0
mmol/l
6.7
6.9
2.58
752
6420
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
979
10701
0.73
6.68
25.8
11.1
u/l
27.2
25.3
1.82
957
10218
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
97
556
1.80
6.61
4.2
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
260
2.16
6.52
1.6
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
18
6.15
6.43
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
151
984
1.60
6.40
12.7
3.8
mmol/l
1.2
1.2
1.26
146
854
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
636
7368
0.75
6.34
4.2
3.6
pmol/l
14.9
15.1
0.95
569
6482
(3005322) IgE [Units/volume] in Serum or Plasma
84
467
1.85
6.33
2.2
1.2
u/ml
1927.5
225.3
0.76
75
426
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
22
5.49
6.29
1.1
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
5
18.10
6.26
2.6
6.6
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
5
18.10
6.26
2.1
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
413
3282
1.36
6.26
2.1
2.2
mg/l
3.8
3.1
3.73
355
2753
(21494890) Protein electrophoresis panel - 24 hour Urine
34
132
2.61
6.23
3.0
2.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
276
3620
0.71
6.21
2.5
3.1
mmol/l
6.9
7.4
1.51
216
2975
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
52
3.69
6.21
1.1
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
191
1322
1.51
6.20
2.3
3.9
ug/l
4.0
22.4
2.21
147
1125
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
18
48
3.78
6.09
1.4
1.3
—
—
—
0
0
(3010421) pH of Blood
69
365
1.94
6.06
5.0
4.7
ph
7.4
7.4
3.95
63
296
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
37
152
2.47
6.06
2.8
4.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
238
1732
1.45
6.00
2.5
2.7
%
22.0
22.2
0.06
212
1475
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
432
3478
1.35
5.97
2.9
2.5
u/l
57.6
57.1
0.03
403
3185
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
125
792
1.63
5.95
1.8
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
447
5406
0.75
5.90
4.1
5.4
ug/l
3.6
4.5
0.37
377
4749
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
45
3.81
5.82
1.2
1.0
u/l
1.8
1.1
—
8
22
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
292
2221
1.40
5.74
2.3
1.7
mg/l
2.1
1.5
1.35
245
1739
(3012516) Albumin [Mass/volume] in Urine
275
3567
0.72
5.71
3.3
3.2
mg/l
2831.5
246.1
2.95
164
2346
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
26
92
2.86
5.69
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
115
2.64
5.66
1.2
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
227
1656
1.44
5.64
10.1
6.6
mmol/l
104.2
104.2
0.04
219
1609
(3037522) Nuclear Ab [Titer] in Serum
163
1113
1.52
5.63
1.3
1.3
titre
680.0
497.0
0.40
26
259
(3004789) Transferrin [Mass/volume] in Serum or Plasma
246
1824
1.42
5.59
2.5
2.6
g/l
2.0
2.2
5.64
229
1671
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
9
7
12.93
5.58
1.2
1.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
68
370
1.88
5.51
1.4
1.5
—
153.3
—
0
15
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
351
4363
0.74
5.50
3.9
4.7
%
21.6
21.8
0.07
160
2264
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3241
1.33
5.42
6.4
3.2
u/l
40.2
35.5
0.87
381
3073
(3032057) Clostridioides difficile [Presence] in Stool
13
30
4.36
5.30
1.8
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
262
1983
1.39
5.27
2.4
2.6
umol/l
11.4
12.1
0.78
244
1816
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
26
4.65
5.26
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
26
4.65
5.26
1.1
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
26
4.65
5.26
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
26
4.65
5.26
1.0
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
317
2477
1.36
5.24
4.0
4.1
ng/l
115.2
343.0
3.67
284
2141
(3027801) Oxygen [Partial pressure] in Arterial blood
212
1548
1.43
5.23
8.1
7.2
kpa
11.5
11.7
0.21
196
1469
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
212
1548
1.43
5.23
8.1
7.2
kpa
4.9
5.1
2.38
194
1469
(40757373) Influenza virus identified in Isolate
14
35
4.03
5.17
1.7
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
35
4.03
5.17
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
263
1998
1.39
5.17
3.3
3.2
e6/l
3.0
1.7
0.58
165
1141
(3003396) Base excess in Arterial blood by calculation
212
1555
1.43
5.10
8.4
7.2
mmol/l
1.4
1.2
0.26
156
1191
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
13
31
4.22
5.09
4.5
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
831
7427
1.28
5.01
5.6
5.0
e6/l
1054.0
2104.6
0.39
16
141
(3036782) Glucose [Moles/volume] in Pleural fluid
37
168
2.23
4.90
1.6
1.4
mmol/l
5.6
6.5
1.26
32
162
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
28
4.31
4.83
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
28
4.31
4.83
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
7
11.48
4.78
1.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
20
5.03
4.78
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
52
273
1.94
4.73
2.5
2.7
%
14.8
15.9
1.19
21
141
(3019225) pH of Specimen
166
1184
1.45
4.64
9.3
4.6
—
—
—
0
0
(3017704) Immunofixation for Urine
22
80
2.78
4.62
1.3
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
5
14.06
4.58
2.3
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
20
70
2.88
4.50
1.7
1.5
%
58.3
64.3
0.22
14
54
(3003338) MCHC [Mass/volume]
728
8096
0.80
4.40
53.5
23.6
g/l
331.0
331.6
0.97
714
7994
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
243
3101
0.74
4.38
2.8
3.3
ug/l
0.8
0.8
0.25
162
2191
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
17
55
3.12
4.37
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
68
400
1.73
4.33
11.4
6.8
mmol/l
1.5
1.4
0.37
58
347
(4027681)
15
45
3.36
4.33
1.3
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
6
11.71
4.28
1.0
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
77
473
1.66
4.20
1.8
3.3
u/ml
32.7
9014.8
0.89
62
401
(3052851) Hemolysis interference index of Serum or Plasma
62
359
1.76
4.18
3.6
3.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
13
6.96
4.16
1.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
14
6.46
3.98
1.1
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
87
2.55
3.97
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
1009
1.44
3.89
2.5
2.4
u/l
34.0
34.3
0.03
118
846
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
82
2.58
3.89
1.0
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
185
1391
1.38
3.85
9.2
7.5
%
95.0
95.1
0.07
175
1338
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
37
186
2.02
3.85
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
48
267
1.83
3.73
2.0
2.8
umol/l
37.3
34.0
0.36
43
219
(3008152) Bicarbonate [Moles/volume] in Arterial blood
122
857
1.46
3.72
9.4
6.6
mmol/l
25.1
24.4
0.85
111
802
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
79
507
1.59
3.66
2.3
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
57
926
0.60
3.58
1.5
1.5
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
15
51
2.96
3.58
1.2
1.4
mmol/l
3.0
3.6
0.29
15
44
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
192
1.95
3.55
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
13
41
3.19
3.50
1.1
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
10
7.03
3.36
1.0
1.2
%
82.3
96.0
—
7
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
10
7.03
3.36
1.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
15
53
2.85
3.36
1.6
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
15
53
2.85
3.36
1.6
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
22
96
2.31
3.27
1.6
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
99
687
1.47
3.24
3.9
3.2
mmol/l
25.0
25.0
0.01
94
668
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
23
103
2.25
3.23
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
130
951
1.40
3.21
4.8
4.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
430
3697
1.23
3.21
3.5
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
291
0.34
3.19
1.7
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
420
4845
0.81
3.19
2.7
2.4
—
—
—
0
0
(4212803)
8
15
5.36
3.19
1.0
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
49
290
1.71
3.14
1.2
1.2
—
1.4
—
0
23
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
98
2.26
3.13
1.2
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
43
246
1.77
3.09
1.7
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
45
2.91
3.03
1.8
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
12
5.86
3.02
1.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
59
371
1.62
3.02
3.3
3.6
mmol/l
24.9
25.0
0.05
49
318
(3001122) Ferritin [Mass/volume] in Serum or Plasma
491
4313
1.21
2.92
3.4
2.8
ug/l
650.8
160.3
11.08
446
3863
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
142
1.99
2.91
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
22
4.11
2.88
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
9
6.69
2.87
1.0
1.0
—
—
—
0
0
(4010399)
48
766
0.61
2.85
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
451
0.50
2.83
1.6
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
121
895
1.38
2.82
3.1
3.9
ng/l
81.4
100.8
0.95
101
764
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
908
0.65
2.82
1.7
1.7
%
1.6
1.6
0.14
50
752
(3018572) Chloride [Moles/volume] in Blood
48
292
1.67
2.81
14.5
7.6
mmol/l
104.0
105.1
0.74
41
262
(3039000) Anion gap in Blood
48
292
1.67
2.81
14.5
7.6
mmol/l
10.1
11.5
2.23
41
262
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
257
2118
1.26
2.78
3.2
3.0
e6/l
1.4
1.1
0.83
159
1257
(3002523) Influenza virus A Ag [Presence] in Specimen
19
84
2.28
2.77
1.8
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
19
84
2.28
2.77
1.8
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
14
5.02
2.73
2.1
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
51
318
1.63
2.72
3.1
3.4
kpa
7.7
7.7
0.04
46
291
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
160
1.89
2.72
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
96
688
1.42
2.69
13.3
10.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
44
265
1.68
2.68
2.1
3.2
u/ml
19.6
1457.5
0.87
39
248
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
15
4.68
2.60
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
44
269
1.66
2.55
2.9
3.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
11
5.47
2.54
1.2
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
101
2.10
2.53
1.1
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
79
553
1.45
2.53
9.0
5.4
%
1.5
1.6
0.30
71
519
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
16
4.39
2.47
1.6
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
136
1049
1.33
2.45
3.7
2.9
kpa
4.8
4.5
0.81
130
1011
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
12
5.02
2.40
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
158
1249
1.30
2.39
10.3
7.9
g/l
110.5
120.7
7.70
149
1204
(3009542) Hematocrit [Volume Fraction] of Blood
826
8820
0.85
2.37
40.3
19.4
%
35.6
38.6
13.08
511
5424
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
176
1.78
2.35
1.1
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
191
2329
0.79
2.35
4.9
4.5
kg/l
1.0
1.0
0.18
36
358
(21494755) Public health laboratory ask at order entry panel
21
391
0.53
2.25
1.4
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
18
3.90
2.25
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
89
656
1.38
2.17
3.1
3.1
e9/l
4.8
4.2
0.28
69
477
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
50
739
0.66
2.16
1.6
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
16
74
2.18
2.15
1.1
1.6
umol/l
16.6
15.5
0.26
16
69
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
106
1376
0.75
2.13
3.3
4.7
%
29.9
32.8
2.59
84
886
(3002256) Pathology report gross observation
171
1390
1.26
2.10
1.4
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
69
2.19
2.05
1.9
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
15
4.01
2.04
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
44
2.51
2.01
1.5
2.5
—
—
—
0
0
(4015189)
11
44
2.51
2.01
1.5
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
19
350
0.54
2.00
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
70
2.15
1.98
5.2
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
172
1409
1.25
1.98
1.3
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
27
449
0.59
1.97
2.5
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
265
3069
0.83
1.97
1.7
1.6
nmol/l
17.7
19.9
1.96
235
2593
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
459
5073
0.86
1.93
2.1
2.1
pmol/l
84.6
92.1
2.90
261
2656
(3014051) Protein [Presence] in Urine by Test strip
12
253
0.47
1.90
3.5
2.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
313
2734
1.19
1.89
1.9
1.8
nmol/l
1172.2
1181.3
0.06
247
2038
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
51
0.00
1.89
0.0
6.4
—
70.3
—
0
42
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
94
717
1.33
1.88
8.5
9.4
mmol/l
23.8
24.4
0.74
88
661
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
63
452
1.41
1.84
2.1
3.2
pmol/l
3.7
4.3
5.35
52
387
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
156
1278
1.25
1.81
3.5
3.1
ng/l
298.3
259.4
0.54
146
1168
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
361
0.58
1.77
1.5
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
176
0.45
1.70
1.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
712
7584
0.88
1.68
4.9
4.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
73
547
1.35
1.67
10.4
5.4
%
0.9
0.9
0.36
66
514
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
149
0.40
1.63
1.0
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
17
91
1.88
1.61
1.2
1.4
—
285.8
—
0
12
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
26
2.70
1.58
2.3
3.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
65
862
0.74
1.57
2.3
2.2
nmol/l
13.3
12.2
0.55
59
735
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
19
323
0.58
1.56
1.7
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
316
1.44
1.52
1.3
1.5
ug/g
233.9
270.1
0.71
25
200
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
44
0.00
1.51
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
21
2.86
1.50
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
14
256
0.54
1.50
1.1
1.1
—
—
—
0
0
(4094501)
14
255
0.54
1.48
1.2
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
7
28
2.51
1.45
2.1
3.4
ml/dl
13.1
14.9
—
7
23
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
120
1454
0.81
1.43
14.9
8.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
984
10219
0.88
1.41
46.9
17.9
mg/l
30.3
28.3
1.04
929
8420
(3008295) Osmolality of Serum or Plasma
20
118
1.70
1.41
1.2
1.3
mosm/kgh2o
270.9
275.8
0.49
15
81
(3011397) Hemoglobin [Presence] in Urine by Test strip
219
2503
0.85
1.39
4.0
3.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
23
2.62
1.37
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
17
2.95
1.36
3.6
4.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
19
112
1.71
1.35
1.2
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
153
1796
0.83
1.33
1.2
1.2
u/ml
2.3
1.6
0.22
36
447
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
184
1.53
1.32
3.0
3.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
193
1.51
1.30
3.7
2.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
35
243
1.45
1.28
1.1
1.2
titre
86.0
97.1
—
5
21
(3037467) Urinalysis macro (dipstick) panel - Urine
790
7510
1.12
1.28
5.2
4.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
242
0.57
1.26
1.6
1.8
nmol/l
43.6
43.3
0.01
14
228
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
11
56
1.97
1.22
1.5
1.2
u/l
68.3
19.8
1.21
11
47
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
113
1345
0.83
1.16
1.2
1.2
u/ml
4.5
14.8
3.15
46
463
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
50
2.01
1.16
5.6
7.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
39
2.06
1.15
1.1
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
39
2.06
1.15
1.1
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
30
2.34
1.12
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
68
542
1.27
1.08
5.1
4.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
775
8096
0.91
1.07
50.4
21.7
%
15.0
14.0
43.51
764
7887
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
287
1.37
1.07
2.2
2.4
g/l
116.0
127.9
2.46
31
216
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
121
1417
0.84
1.06
1.2
1.2
iu/ml
37.7
40.2
0.05
37
428
(3009261) Glucose [Presence] in Urine by Test strip
491
5240
0.90
1.05
4.4
4.0
estimate
0.0
0.0
0.50
136
985
(3014891) Appearance of Pleural fluid
7
34
2.06
1.03
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
23
155
1.49
1.01
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
76
1.72
0.99
2.0
2.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
11
61
1.81
0.98
1.5
1.2
u/l
151.2
84.0
0.58
11
53
(3021601) Nitrite [Presence] in Urine by Test strip
485
5164
0.91
0.98
5.7
5.4
estimate
0.0
0.0
0.00
136
1007
(3035350) Ketones [Presence] in Urine by Test strip
489
5195
0.91
0.93
4.3
4.0
estimate
0.0
0.0
0.00
136
1009
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
9
52
1.74
0.92
1.1
1.1
u/l
112.3
81.7
—
9
38
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
29
2.07
0.89
1.5
1.3
ug/l
16.8
9.0
—
6
29
(3034770) Mitochondria Ab [Titer] in Serum
34
254
1.35
0.89
1.1
1.2
—
734.4
—
0
9
(3003181) Sodium [Moles/volume] in Urine
32
237
1.36
0.88
1.4
1.3
mmol/l
69.1
63.3
0.31
27
194
(3037121) Protein [Mass/volume] in Urine
55
442
1.25
0.86
2.7
2.9
g/l
0.3
0.3
0.10
27
169
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
72
1.67
0.85
2.4
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
320
0.71
0.84
2.0
2.4
ug/min
170.8
95.7
0.28
14
194
(3021788) Differential panel - Synovial fluid
15
225
0.66
0.82
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
352
0.73
0.81
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
106
1.52
0.79
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
11
66
1.67
0.78
1.8
1.6
u/l
1.2
9.5
—
5
34
(3036071) Salmonella sp Ab [Titer] in Serum
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.3
—
123.7
—
0
20
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
115
1006
1.16
0.76
1.4
1.3
—
—
—
0
0
(4034850)
25
336
0.74
0.76
19.4
11.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
504
4781
1.08
0.75
4.4
4.3
ng/l
34.4
68.1
2.49
413
3731
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
140
1244
1.14
0.74
1.9
2.6
ug/l
5.0
6.5
0.62
116
1070
(3027944) Amphetamines [Presence] in Urine
6
108
0.55
0.72
1.0
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
438
4143
1.08
0.70
3.3
3.2
ng/l
2914.4
2003.4
1.22
386
3596
(3002331) Protein [Mass/volume] in Peritoneal fluid
5
27
1.85
0.68
1.0
1.7
g/l
26.4
26.6
—
5
21
(3011648) Oxygen content in Venous blood
5
92
0.54
0.67
1.2
1.9
%
11.7
10.9
—
5
92
(36660697) Celiac disease serology panel - Serum
53
632
0.83
0.63
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
200
0.70
0.63
1.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
103
0.58
0.62
1.0
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
50
416
1.21
0.61
4.3
3.5
mmol/l
3.7
4.0
2.85
42
380
(40762814) Titanium [Mass/volume] in Blood
0
20
0.00
0.60
0.0
2.1
—
2.8
—
0
7
(3044941) Cell count panel - Synovial fluid
14
196
0.71
0.57
1.6
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
37
1.62
0.55
3.3
3.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
37
1.62
0.55
1.0
2.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
37
303
1.23
0.54
4.0
3.4
mmol/l
7.1
7.9
1.35
37
297
(3044242) Glucose [Moles/volume] in Arterial blood
12
82
1.47
0.54
1.4
2.5
—
—
—
0
0
(3013512) EKG study
335
3536
0.93
0.54
5.0
4.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
39
322
1.22
0.53
3.9
3.3
mmol/l
1.6
1.7
0.29
39
315
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
215
0.74
0.52
1.8
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
29
232
1.26
0.52
1.4
1.2
u/l
66.9
46.6
0.26
22
204
(3000475) Leukocytes [#/volume] in Synovial fluid
23
292
0.78
0.51
2.3
1.6
e6/l
11420.8
17039.4
0.60
16
207
(3020961) Endomysium IgA Ab [Titer] in Serum
27
336
0.80
0.51
1.1
1.1
—
162.2
—
0
5
(3022217) INR in Platelet poor plasma by Coagulation assay
210
1957
1.09
0.50
26.5
30.9
inr
1.3
1.5
2.12
37
267
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
381
3993
0.94
0.50
4.7
4.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
51
594
0.85
0.50
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
66
752
0.87
0.49
3.0
3.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
44
372
1.19
0.49
3.9
4.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
108
0.65
0.48
1.0
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
109
0.64
0.48
1.0
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
109
0.64
0.48
1.0
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
21
163
1.29
0.48
1.3
1.2
u/ml
53.7
31.9
—
5
10
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
47
1.49
0.47
1.7
1.3
u/l
29.4
28.3
—
7
37
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
16
120
1.34
0.46
1.2
1.2
nmol/l
0.8
0.6
0.39
16
110
(3026470) Cobalt [Mass/volume] in Blood
5
85
0.59
0.45
2.4
2.0
ug/l
2.8
3.3
—
5
75
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
330
0.81
0.45
1.5
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
15
112
1.34
0.44
1.1
1.2
—
69.2
—
0
7
(46235168) Fasting glucose [Moles/volume] in Blood
0
15
0.00
0.41
0.0
2.1
—
8.0
—
0
10
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
124
1.29
0.38
5.4
3.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
159
0.75
0.38
1.8
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
192
0.78
0.38
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
68
1.33
0.37
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
68
1.33
0.37
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
68
1.33
0.37
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
69
1.31
0.37
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
69
1.31
0.37
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
69
1.31
0.37
1.2
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
15
116
1.30
0.37
1.9
2.1
u/field
0.7
2.4
—
6
38
(3017569) Oxygen content in Arterial blood
9
70
1.29
0.36
2.6
2.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
71
640
1.12
0.36
2.4
2.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
300
1.17
0.36
1.7
1.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
42
1.43
0.35
1.0
1.1
—
7.2
—
0
9
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
122
0.74
0.35
1.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
211
0.80
0.34
1.2
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
44
1.37
0.34
8.8
2.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
57
636
0.89
0.34
3.9
4.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
425
0.87
0.34
1.1
1.2
iu/ml
75.3
131.3
0.67
12
150
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
87
0.69
0.33
1.0
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
101
934
1.09
0.32
2.0
2.1
ug/g
158.2
158.8
0.01
82
736
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
110
1.28
0.31
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
260
2713
0.95
0.31
1.6
1.8
pmol/l
547.0
8534241.6
1.00
212
2203
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
97
0.72
0.31
1.1
1.8
—
—
—
0
0
(3004451) EKG impression Narrative
10
75
1.34
0.30
1.8
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
75
1.34
0.30
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
75
1.34
0.30
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
139
0.79
0.27
1.8
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
67
1.20
0.26
2.3
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
95
1.27
0.26
1.2
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
33
373
0.88
0.26
2.7
3.3
nmol/l
1.0
0.8
0.56
24
285
(3024928) Oxygen saturation in Venous blood
32
282
1.14
0.25
2.4
2.7
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
137
0.80
0.24
1.6
2.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
6
82
0.73
0.24
1.0
2.5
mmol/l
8.4
7.3
—
6
48
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
83
0.72
0.24
1.2
1.1
—
62.0
—
0
8
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
39
1.28
0.23
7.2
2.8
%
13.9
13.2
—
5
39
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
135
0.81
0.22
1.0
1.1
g/l
1.7
1.6
0.49
11
123
(3025315) Body weight
0
10
0.00
0.21
0.0
4.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
0
10
0.00
0.21
0.0
2.1
—
63.8
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.9
—
15.2
—
0
12
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
103
0.78
0.21
1.4
1.1
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
1036.7
—
0
5
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
191.3
—
0
7
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
48
1.25
0.20
13.5
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
48
1.25
0.20
13.5
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
108
1.21
0.20
1.2
1.2
nmol/l
—
—
—
0
0
(3012565) Volume of 24 hour Urine
6
53
1.13
0.18
3.0
2.9
ml
1681.7
1938.5
—
6
44
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
31
280
1.11
0.18
2.1
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
875
0.95
0.17
2.3
1.6
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
8
72
1.11
0.16
1.0
1.0
mg/l
302.4
294.5
—
8
65
(4268621)
6
79
0.76
0.15
3.0
2.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
121
1.16
0.15
1.2
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
7
88
0.79
0.14
1.3
1.1
mmol/l
28.4
34.5
—
7
82
(3022145) Colonoscopy Study observation
115
1108
1.04
0.14
1.2
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
128
0.86
0.13
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
84
876
0.96
0.13
3.3
3.2
ml/min/173m2
56.4
59.7
0.27
26
387
(3041096) Erythrocytes [Presence] in Urine by Automated
278
2725
1.03
0.12
4.3
3.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
617
6103
1.02
0.12
4.3
3.2
u/l
81.2
56.2
3.70
574
5561
(3029937) Albumin [Presence] in Urine by Test strip
286
2909
0.98
0.10
4.8
4.3
estimate
0.0
0.0
0.50
126
945
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
124
0.89
0.09
1.1
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
365
3607
1.02
0.08
2.0
2.2
u/l
137.2
236.8
2.60
342
3359
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
61
0.82
0.08
1.2
1.5
g/l
0.9
0.9
—
5
61
(3032773) Endomysium IgG Ab [Titer] in Serum
5
62
0.81
0.08
1.2
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
65
0.77
0.08
1.8
1.8
—
47.5
—
0
5
(3014271) Vancomycin [Susceptibility]
8
91
0.88
0.06
2.3
3.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
282
0.96
0.04
3.0
3.8
mg/l
40.6
29.8
0.95
18
185
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
158
0.95
0.02
2.1
2.5
mg/l
29.5
20.4
—
6
37
(40761535) Cells panel - Urine sediment
104
1029
1.01
0.02
3.9
3.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
417
4182
1.00
0.01
2.2
2.2
nmol/l
76.9
78.3
0.45
381
3600
(3015736) pH of Urine
405
4059
1.00
0.01
3.8
3.8
—
6.1
—
0
5
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
17
174
0.98
0.00
1.2
1.6
iu/l
8.8
5.1
—
5
48
(4306422)
10
102
0.98
0.00
1.5
1.2
—
—
—
0
0
(3000492) Spirometry study
84
844
0.99
0.00
1.5
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
10
101
0.99
0.00
1.7
2.2
ml
592.2
659.2
—
5
61
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
109
1.01
0.00
1.4
1.2
u/ml
2.7
6.5
—
6
52
(3049717) Cytology report of Urine Cyto stain
63
625
1.01
0.00
2.4
2.8
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
61
0.98
0.00
2.2
1.8
nmol/l
14.3
17.7
—
6
51
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
22.6
—
0
8
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
6.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
5
52
0.96
0.00
1.0
1.3
nmol/l
1.3
1.0
—
5
38
(3044009) aPTT.lupus sensitive (LA screen)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
43.3
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
70
1.00
0.00
3.0
2.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.2
—
384.8
—
0
5
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
37
370
1.00
0.00
1.4
1.3
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
72
0.97
0.00
1.3
1.5
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
58
0.86
0.00
1.0
1.1
nmol/l
111.4
136.4
—
5
58
(4281824)
9
93
0.97
0.00
1.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
76
0.92
0.00
6.6
16.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
362.6
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_NONHODGKIN – Non-Hodgkin lymphoma, all

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).